Compugen (CGEN) Non Operating Income (2009 - 2026)
Compugen's (CGEN) quarterly Non Operating Income came in at $1.4 million in Q1 2026, up 8.67% year-on-year from $1.2 million in Q1 2025, and up 68.7% quarter-over-quarter from $802000.0 in Q4 2025.
Compugen (CGEN) Non Operating Income (2009 - 2026) Analysis & Trends
Compugen has disclosed Non Operating Income across 18 years of filings, most recently posting $1.4 million for Q1 2026.
- Non Operating Income for Q1 2026 came in at $1.4 million, up 8.67% year-over-year; the trailing twelve-month figure through Mar 2026 was $4.2 million (down 19.62% YoY), and the FY2025 annual result was $4.1 million, down 21.44% from the prior year.
- Non Operating Income came in at $1.4 million for Q1 2026 at Compugen, up from $802000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $1.4 million in Q4 2024 to a low of $286000.0 in Q1 2022.
- The 5-year median for Non Operating Income is $889000.0 (2023), against an average of $914823.5.
- Across the five-year window, Non Operating Income surged 266.67% in 2022 and sank 41.46% in 2025, its largest moves.
- Compugen's Non Operating Income stood at $495000.0 in 2022, then jumped by 48.48% to $735000.0 in 2023, then soared by 86.39% to $1.4 million in 2024, then tumbled by 41.46% to $802000.0 in 2025, then jumped by 68.7% to $1.4 million in 2026.
- The last three Non Operating Income figures came in at $1.4 million (Q1 2026), $802000.0 (Q4 2025), and $954000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | - |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 444,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 9.35 Mn |
| 10 | Compugen | 189.59 Mn | 97.83 Mn | 352,000.00 | 1.35 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.35 Mn |
| Dec 31, 2025 | 802,000.00 |
| Sep 30, 2025 | 954,000.00 |
| Jun 30, 2025 | 1.07 Mn |
| Mar 31, 2025 | 1.25 Mn |
| Dec 31, 2024 | 1.37 Mn |
| Sep 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | 1.30 Mn |
| Mar 31, 2024 | 1.23 Mn |
| Dec 31, 2023 | 735,000.00 |
| Sep 30, 2023 | 776,000.00 |
| Jun 30, 2023 | 889,000.00 |
| Mar 31, 2023 | 808,000.00 |
| Dec 31, 2022 | 495,000.00 |
| Sep 30, 2022 | 464,000.00 |
| Jun 30, 2022 | 493,000.00 |
| Mar 31, 2022 | 286,000.00 |
| Dec 31, 2021 | 135,000.00 |
| Sep 30, 2021 | 177,000.00 |
| Jun 30, 2021 | 200,000.00 |